4.8 Article

A class of highly selective inhibitors bind to an active state of PI3Kγ

Journal

NATURE CHEMICAL BIOLOGY
Volume 15, Issue 4, Pages 348-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41589-018-0215-0

Keywords

-

Funding

  1. Medical Research Council [MC_U105184308]
  2. MRC-AstraZeneca/MedImmune Blue Sky Collaborative Research Grant [MC_A024-5PF9G]
  3. Swiss Commission for Technology and Innovation
  4. Stiftung fur Krebsbekampfung Grant [341]
  5. Swiss National Science Foundation [310030_153211, 316030_133860]
  6. MRC [MC_U105184308] Funding Source: UKRI
  7. Swiss National Science Foundation (SNF) [316030_133860, 310030_153211] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

We have discovered a class of PI3K gamma inhibitors exhibiting over 1,000-fold selectivity over PI3K alpha and PI3K beta. On the basis of X-ray crystallography, hydrogen-deuterium exchange-mass spectrometry and surface plasmon resonance experiments we propose that the cyclopropylethyl moiety displaces the DFG motif of the enzyme away from the adenosine tri-phosphate binding site, inducing a large conformational change in both the kinase- and helical domains of PI3K gamma. Site directed mutagenesis explained how the conformational changes occur. Our results suggest that these cyclopropylethyl substituted compounds selectively inhibit the active state of PI3K gamma, which is unique to these compounds and to the PI3K gamma isoform, explaining their excellent potency and unmatched isoform selectivity that were confirmed in cellular systems. This is the first example of a Class I PI3K inhibitor achieving its selectivity by affecting the DFG motif in a manner that bears similarity to DFG in/out for type II protein kinase inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available